Endocrinopathies in thalassemia

Main Article Content

กิตติ ต่อจรัส




Article Details

บทบรรณาธิการ (Editorial)


1. Thuret I, Pondarre C, Loundou A, Steschenko D, Girot R, Bachir D,et al. Complications and treatment of patients with beta-thalassemia in France: results of the National Registry. Haematologica.2010;95:724-9.
2. Wu HP, Lin CL, Chang YC, Wu KH, Lei RL, Peng CT, et al. Survival and complication rates in patients with thalassemia major in Taiwan. Pediatr Blood Cancer. 2017;64:135-8.
3. Kanbour I, Chandra P, Soliman A, De Sanctis V, Nashwan A, Abusamaan S, et al. Severe Liver Iron Concentrations (LIC) in 24 Patients with beta-Thalassemia Major: Correlations with Serum Ferritin, Liver Enzymes and Endocrine Complications. MediterrJ Hematol Infect Dis. 2018;10:e2018062.
4. Soliman AT, De Sanctis V, Elalaily R, Yassin M. Insulin-like growth factor- I and factors affecting it in thalassemia major. Indian J Endocrinol Metab. 2015;19:245-51.
5. De Sanctis V, Soliman AT, Candini G, Yassin M, Raiola G, Galati MC, et al. Insulin-like Growth Factor-1 (IGF-1): Demographic, Clinical and Laboratory Data in 120 Consecutive Adult Patients with Thalassaemia Major. Mediterr J Hematol Infect Dis. 2014;6:e2014074.
6. Bazi A, Sharifi-Rad J, Rostami D, Sargazi-Aval O, Safa A. Diabetes Mellitus in Thalassaemia Major Patients: A Report from the Southeast of Iran. J Clin Diagn Res. 2017;11:bc01-bc4.
7. Bazi A, Harati H, Khosravi-Bonjar A, Rakhshani E, Delaramnasab M. Hypothyroidism and Hypoparathyroidism in Thalassemia Major Patients: A Study in Sistan and Baluchestan Province, Iran. Int J Endocrinol Metab. 2018;16:e13228.
8. Kurtoglu AU, Kurtoglu E, Temizkan AK. Effect of iron overload on endocrinopathies in patients with beta-thalassaemia major and intermedia. Endokrynol Pol. 2012;63:260-3.
9. Baldini M, Marcon A, Cassin R, Ulivieri FM, Spinelli D, Cappellini MD, et al. Beta-thalassaemia intermedia: evaluation of endocrine and bone complications. BioMed Res Int. 2014;2014:174581